| Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective M Tomblyn, T Chiller, H Einsele, R Gress, K Sepkowitz, J Storek, ... Biology of blood and marrow transplantation 15 (10), 1143-1238, 2009 | 2271 | 2009 |
| Cord-blood engraftment with ex vivo mesenchymal-cell coculture M De Lima, I McNiece, SN Robinson, M Munsell, M Eapen, M Horowitz, ... New England Journal of Medicine 367 (24), 2305-2315, 2012 | 547 | 2012 |
| Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure M Duval, JP Klein, W He, JY Cahn, M Cairo, BM Camitta, R Kamble, ... Journal of clinical oncology 28 (23), 3730-3738, 2010 | 546 | 2010 |
| Maintenance therapy with low‐dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a … M De Lima, S Giralt, PF Thall, L de Padua Silva, RB Jones, K Komanduri, ... Cancer 116 (23), 5420-5431, 2010 | 502 | 2010 |
| Acute myeloid leukemia, version 3.2019, NCCN clinical practice guidelines in oncology MS Tallman, ES Wang, JK Altman, FR Appelbaum, VR Bhatt, D Bixby, ... Journal of the National Comprehensive Cancer Network 17 (6), 721-749, 2019 | 468 | 2019 |
| Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology MR O'Donnell, MS Tallman, CN Abboud, JK Altman, FR Appelbaum, ... Journal of the National Comprehensive Cancer Network 15 (7), 926-957, 2017 | 448 | 2017 |
| Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term … M De Lima, A Anagnostopoulos, M Munsell, M Shahjahan, N Ueno, ... Blood 104 (3), 865-872, 2004 | 444 | 2004 |
| Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and … IF Khouri, P McLaughlin, RM Saliba, C Hosing, M Korbling, MS Lee, ... Blood, The Journal of the American Society of Hematology 111 (12), 5530-5536, 2008 | 379 | 2008 |
| Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC … ML Sorror, S Giralt, BM Sandmaier, M De Lima, M Shahjahan, ... Blood, The Journal of the American Society of Hematology 110 (13), 4606-4613, 2007 | 376 | 2007 |
| Survival of patients with acute myeloid leukemia relapsing after allogeneic hematopoietic cell transplantation: a center for international blood and marrow transplant research … N Bejanyan, DJ Weisdorf, BR Logan, HL Wang, SM Devine, M de Lima, ... Biology of Blood and Marrow Transplantation 21 (3), 454-459, 2015 | 373 | 2015 |
| Tumor necrosis factor-α blockade for the treatment of acute GVHD D Couriel, R Saliba, K Hicks, C Ippoliti, M De Lima, C Hosing, I Khouri, ... Blood 104 (3), 649-654, 2004 | 335 | 2004 |
| Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD DR Couriel, C Hosing, R Saliba, EJ Shpall, P Anderlini, B Rhodes, ... Blood 107 (8), 3074-3080, 2006 | 331 | 2006 |
| High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation SO Ciurea, M De Lima, P Cano, M Korbling, S Giralt, EJ Shpall, X Wang, ... Transplantation 88 (8), 1019-1024, 2009 | 320 | 2009 |
| Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation SO Ciurea, V Mulanovich, RM Saliba, UD Bayraktar, Y Jiang, R Bassett, ... Biology of Blood and Marrow Transplantation 18 (12), 1835-1844, 2012 | 303 | 2012 |
| Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using … CG Kanakry, PV O'Donnell, T Furlong, MJ De Lima, W Wei, M Medeot, ... Journal of Clinical Oncology 32 (31), 3497-3505, 2014 | 297 | 2014 |
| Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells SN Robinson, J Ng, T Niu, H Yang, JD McMannis, S Karandish, I Kaur, ... Bone marrow transplantation 37 (4), 359-366, 2006 | 296 | 2006 |
| Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid … E Estey, M De Lima, R Tibes, S Pierce, H Kantarjian, R Champlin, S Giralt Blood 109 (4), 1395-1400, 2007 | 285 | 2007 |
| Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation DR Couriel, RM Saliba, S Giralt, I Khouri, B Andersson, M de Lima, ... Biology of blood and marrow transplantation 10 (3), 178-185, 2004 | 270 | 2004 |
| Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect KW Van Besien, M De Lima, SA Giralt, M DF Jr, IF Khouri, G Rondon, ... Bone Marrow Transplantation 19 (10), 977-982, 1997 | 268 | 1997 |
| Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for iv BuCy2 in chronic myelogenous leukemia BS Andersson, PF Thall, T Madden, D Couriel, X Wang, HT Tran, ... Biology of Blood and Marrow Transplantation 8 (9), 477-485, 2002 | 267 | 2002 |